Telo Genomics Corp. (TSXV: TELO) Stock Analysis & Fundamentals | ScreenerHero

Create free account

TELOTelo Genomics Corp.

TSXV · CA · Healthcare · Diagnostics & Research · telodx.com

0.0450CAD-10.00%Mkt Cap: 3.29M $P/E: —5d ago

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily …

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$213.32BUSDP/E 30.8

Danaher Corporation

$138.84BUSDP/E 35.1

$44.66BUSDP/E 36.1

IDEXX Laboratories, Inc.

$44.79BUSDP/E 41.8

Agilent Technologies, Inc.

$39.48BUSDP/E 28.1

IQVIA Holdings Inc.

$38.41BUSDP/E 29.0

Waters Corporation

$36.79BUSDP/E 47.7

$29.98BUSDP/E 37.0

Mettler-Toledo International Inc.

$29.20BUSDP/E 32.6

Quest Diagnostics Incorporated

$25.60BUSDP/E 24.6

Labcorp Holdings Inc.

$24.87BUSDP/E 25.4

Guardant Health, Inc.

Medpace Holdings, Inc.

$16.00BUSDP/E 33.7

Eurofins Scientific SE

$12.72BUSDP/E 23.5

$12.85BUSDP/E 55.4

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 18.5

BillionToOne, Inc.

$6.32BUSDP/E 254.3

Twist Bioscience Corporation

Sotera Health Company

$5.13BUSDP/E 43.9

DiaSorin S.p.A.

$4.04BUSDP/E 28.5

Adaptive Biotechnologies Corporation

$3.58BUSDP/E 32.0

$2.48BUSDP/E 23.0

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.76BUSDP/E 45.1

Diagnostyka S.A.

$1.43BUSDP/E 21.7

Personalis, Inc.

Clínica Baviera, S.A.

$1.06BUSDP/E 21.2

OPKO Health, Inc.

Castle Biosciences, Inc.

$639.18MUSDP/E 41.6

Fulgent Genetics, Inc.

$335.15MUSDP/E 3.4

Spectral Medical Inc.

Myriad Genetics, Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Biomark Diagnostics Inc.

Abingdon Health Plc

Immunovia AB (publ)

Izotropic Corporation

Proteome Sciences plc

Oxford BioDynamics Plc

ENDRA Life Sciences Inc.

Avricore Health Inc.

Leveljump Healthcare Corp.

bioAffinity Technologies, Inc.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap3.29M $

Enterprise Value3.54M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-1.98M $

Revenue/Share—

Last Price0.0450 CAD

Fiscal Year EndJun 2025

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISINCA87975M2085

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-2.59

EV/Revenue—

P/S—

P/B-4.50

EPS (TTM)-0.03

EPS (Forward)—

52W Range

0.035015% of range0.1000

52W High0.1000 CAD

52W Low0.0350 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-527.93%

ROA-298.34%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.70M $

CapEx (TTM)2.37K $

FCF Margin—

FCF Yield-8.97%

Net Debt247.31K $

Net Debt/EBITDA-0.18

Balance Sheet

Debt/Equity—

Current Ratio0.09

Quick Ratio0.07

Book Value/Sh-0.0100 CAD

Cash/Share0.0100 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateNov 22, 2019

Splits

Last Split1:5

Split DateNov 22, 2019

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.100.43M

Float74.45M

Insiders2.98%

Institutions0.40%

Short Interest

Short Ratio0.1d

Short % Out.0.00%

Shares Short14.30K

Short (prev mo.)5.82K

Technical

SMA 500.0508 (-11.4%)

SMA 2000.0520 (-13.4%)

Beta—

S&P 52W Chg18.32%

Avg Vol (30d)37.74K

Avg Vol (10d)12.25K

Technical Indicators

RSI (14)47.1

MACD-0.0024

MACD Signal-0.0030

MACD Hist.+0.0006

BB Upper0.0493 CAD

BB Middle0.0437 CAD

BB Lower0.0382 CAD

BB Width25.15%

ATR (14)0.0037 CAD

Vol Ratio (20d)0.03x